Announcements Trials
Browse Landscape

Status

Unknown 5Recruiting 4Not yet recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 37Observational 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Cervical Cancer Metastatic 1

Interventions

Observation 21Blood Specimen Collection 20Drug Therapy 13Surveys and Questionnaires 8Surgical Procedures, Operative 8Immunotherapy 7Immune Checkpoint Inhibitors 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Indocyanine Green 3Imatinib Mesylate 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3tislelizumab 2pertuzumab 2palbociclib 2obinutuzumab 2nilotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × camrelizumab × Clear all
NCT07266350 2025-12-05

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Chongqing University Cancer Hospital

Not yet recruiting
1,300 enrolled
Gynecologic

Cervical Cancer Metastatic

NCT04616040 2020-11-04

A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer

Peking University

Not yet recruiting
1,030 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡